Search

Your search keyword '"Respiratory Syncytial Virus, Human chemistry"' showing total 91 results

Search Constraints

Start Over You searched for: Descriptor "Respiratory Syncytial Virus, Human chemistry" Remove constraint Descriptor: "Respiratory Syncytial Virus, Human chemistry"
91 results on '"Respiratory Syncytial Virus, Human chemistry"'

Search Results

1. Assembly of respiratory syncytial virus matrix protein lattice and its coordination with fusion glycoprotein trimers.

2. A human antibody potently neutralizes RSV by targeting the conserved hydrophobic region of prefusion F.

3. Structural modeling, energetic analysis and molecular design of a π-stacking system at the complex interface of pediatric respiratory syncytial virus nucleocapsid with the C-terminal peptide of phosphoprotein.

4. Biophysical studies of the interaction of hRSV Non-Structural 1 protein with natural flavonoids and their acetylated derivatives by spectroscopic techniques and computational simulations.

5. A finely tuned interplay between calcium binding, ionic strength and pH modulates conformational and oligomerization equilibria in the Respiratory Syncytial Virus Matrix (M) protein.

6. Importance of RNA length for in vitro encapsidation by the nucleoprotein of human respiratory syncytial virus.

7. Hesperetin targets the hydrophobic pocket of the nucleoprotein/phosphoprotein binding site of human respiratory syncytial virus.

8. Helical ordering of envelope-associated proteins and glycoproteins in respiratory syncytial virus.

9. Respiratory Syncytial Virus Phosphoprotein Residue S156 Plays a Role in Regulating Genome Transcription and Replication.

10. Targeting the membrane fusion event of human respiratory syncytial virus with rationally designed α-helical hairpin traps.

11. Potent Human Single-Domain Antibodies Specific for a Novel Prefusion Epitope of Respiratory Syncytial Virus F Glycoprotein.

12. A Structural and Dynamic Analysis of the Partially Disordered Polymerase-Binding Domain in RSV Phosphoprotein.

13. Functional Features of the Respiratory Syncytial Virus G Protein.

14. Structural Insights into the Respiratory Syncytial Virus RNA Synthesis Complexes.

15. Respiratory Syncytial Virus (RSV) G Protein Vaccines With Central Conserved Domain Mutations Induce CX3C-CX3CR1 Blocking Antibodies.

16. Structural Characterization and Modeling of a Respiratory Syncytial Virus Fusion Glycoprotein Nanoparticle Vaccine in Solution.

17. A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain.

18. In vitro trackable assembly of RNA-specific nucleocapsids of the respiratory syncytial virus.

19. A conformational switch balances viral RNA accessibility and protection in a nucleocapsid ring model.

20. Alternative conformations of a major antigenic site on RSV F.

21. Discovery of Ziresovir as a Potent, Selective, and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein Inhibitor.

22. Conformational Isomerization Involving Conserved Proline Residues Modulates Oligomerization of the NS1 Interferon Response Inhibitor from the Syncytial Respiratory Virus.

23. Evaluation of the role of respiratory syncytial virus surface glycoproteins F and G on viral stability and replication: implications for future vaccine design.

24. The Structure of the Human Respiratory Syncytial Virus M2-1 Protein Bound to the Interaction Domain of the Phosphoprotein P Defines the Orientation of the Complex.

25. Protective antigenic sites in respiratory syncytial virus G attachment protein outside the central conserved and cysteine noose domains.

26. Binding investigation between M2-1protein from hRSV and acetylated quercetin derivatives: 1 H NMR, fluorescence spectroscopy, and molecular docking.

27. Structure and Function of the Human Respiratory Syncytial Virus M2-1 Protein.

28. Structure and stability of the Human respiratory syncytial virus M 2-1 RNA-binding core domain reveals a compact and cooperative folding unit.

29. Molecular evolution of the fusion protein (F) gene in human respiratory syncytial virus subgroup B.

30. A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.

31. Modulation of the host immune response by respiratory syncytial virus proteins.

32. Structural, antigenic and immunogenic features of respiratory syncytial virus glycoproteins relevant for vaccine development.

33. A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant.

34. Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity.

35. Peptide presentation on primate erythroparvovirus 1 virus-like particles: In vitro assembly, stability and immunological properties.

36. Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV.

37. Human CD8(+) T Cells Target Multiple Epitopes in Respiratory Syncytial Virus Polymerase.

38. Intrinsic Disorder to Order Transitions in the Scaffold Phosphoprotein P from the Respiratory Syncytial Virus RNA Polymerase Complex.

39. A Druggable Pocket at the Nucleocapsid/Phosphoprotein Interaction Site of Human Respiratory Syncytial Virus.

40. Conservation of G-Protein Epitopes in Respiratory Syncytial Virus (Group A) Despite Broad Genetic Diversity: Is Antibody Selection Involved in Virus Evolution?

41. The viral transcription group determines the HLA class I cellular immune response against human respiratory syncytial virus.

42. Scop3D: three-dimensional visualization of sequence conservation.

43. Quantitative investigation of the affinity of human respiratory syncytial virus phosphoprotein C-terminus binding to nucleocapsid protein.

44. Polyclonal and monoclonal antibodies specific for the six-helix bundle of the human respiratory syncytial virus fusion glycoprotein as probes of the protein post-fusion conformation.

45. Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses.

46. Fine modulation of the respiratory syncytial virus M2-1 protein quaternary structure by reversible zinc removal from its Cys(3)-His(1) motif.

47. Genetic analysis of attachment glycoprotein (G) gene in new genotype ON1 of human respiratory syncytial virus detected in Japan.

48. The respiratory syncytial virus nucleoprotein-RNA complex forms a left-handed helical nucleocapsid.

49. Architecture of respiratory syncytial virus revealed by electron cryotomography.

50. Challenges and opportunities for respiratory syncytial virus vaccines.

Catalog

Books, media, physical & digital resources